Johnson & Johnson has begun a clinical trial for assessment of the safety and immunogenicity
of its under development Ebola prime-boost vaccine regimen in Sierra Leone.
com)-- Cambridge Healthtech Institute (CHI) today announced the FDA and keynote speakers confirmed to present at its seventh annual Immunogenicity
and Bioassay Summit 2015 being held on November 17-19, 2015 at the Hilton Baltimore in Baltimore, MD.
NASDAQ: BVXV, TASE: BVXV) today announced it received the statistical analysis of results from a study which demonstrates that BiondVax's universal flu vaccine (M-001), administered in the BVX-005 phase II trial which took place in 2012, provided participants with increased immunogenicity
against future strains which did not exist at the time of the study- in particular the current newly emerged H3N2 influenza (flu) strain that caused the epidemic in the United States in 2015.
Antitope Limited, an Abzena company, has collaborated with Synthon Biopharmaceuticals BV (Synthon), a global pharmaceutical company with expertise in the development of complex small molecule and biosimilar drugs and new biopharmaceuticals, including antibody drug conjugates (ADC), to assess the potential immunogenicity
of candidate antibodies for Synthon's ADC programmes.
Therefore, researchers all over the country look for new approaches to increase immunogenicity
of the vaccine.
Under the terms of the agreement Annexon will provide antibodies against specific components of the complement system and Antitope will use its Composite Human Antibody technology to generate a series of fully humanised antibodies devoid of T cell epitopes and with a consequent low risk of clinical immunogenicity
Under this agreement, Antitope will apply its Composite Human Antibody technology to generate fully humanised antibodies devoid of T cell epitopes with a consequent very low risk of clinical immunogenicity
This article will review the published data regarding immunogenicity
of biologic therapy and will discuss the impact of AABs on treatment outcomes.
LONDON, April 5, 2011 /PRNewswire/ -- This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ to discuss FDA directives on immunogenicity
introduced in 2008.
The phase II study includes the vaccination of 400 mechanically ventilated intensive care patients, who are at a high risk of getting Pseudomonas aeruginosa infections, with Intercell's vaccine and explores the safety and immunogenicity
of the vaccine and the rates of Pseudomonas infection.
Immunoinformatics; predicting immunogenicity
Block reported that the two intranasal FluMist formulations had equivalent immunogenicity
against three influenza strains (two type A and one type B).